{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:22:00Z","timestamp":1792718520212,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T00:00:00Z","timestamp":1451260800000},"content-version":"vor","delay-in-days":3648,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2006]]},"DOI":"10.1111\/j.1469-0691.2006.01394.x","type":"journal-article","created":{"date-parts":[[2006,4,18]],"date-time":"2006-04-18T08:27:34Z","timestamp":1145348854000},"page":"25-30","source":"Crossref","is-referenced-by-count":57,"special_numbering":"S3","title":["Legionella: macrolides or quinolones?"],"prefix":"10.1016","volume":"12","author":[{"given":"L.","family":"Pedro-Botet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.L.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2006.01394.x_bib1","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJM197712012972201","article-title":"Legionnaire's disease: description of an epidemic of pneumonia","volume":"297","author":"Fraser","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib2","first-page":"52","article-title":"Nosocomial outbreak of Legionnaire's disease at the Pittsburgh Veterans Administration Medical Center","volume":"93","author":"Brown","year":"1980","journal-title":"Trans Assoc Am Physicians"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib3","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00005792-198005000-00002","article-title":"Legionnaire's disease: report of sixty\u2010five nosocomially\u2010acquired cases and review of the literature","volume":"59","author":"Kirby","year":"1980","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev.me.31.020180.001251","article-title":"Legionnaire's disease","volume":"31","author":"Meyer","year":"1980","journal-title":"Annu Rev Med"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib5","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1097\/00007611-198111000-00036","article-title":"Failure of oral erythromycin therapy for Legionnaire's disease in a renal transplant recipient","volume":"74","author":"Hays","year":"1981","journal-title":"South Med J"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0163-4453(85)92838-5","article-title":"Failure of erythromycin\/rifampicin treatment of Legionella pneumonia","volume":"10","author":"Mercatello","year":"1985","journal-title":"J Infect"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0002-9343(84)90793-9","article-title":"Failure of erythromycin in treatment of Legionella micdadei pneumonia","volume":"76","author":"Rudin","year":"1984","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1172\/JCI110744","article-title":"Intracellular multiplication of Legionnaire's disease bacteria (Legionella pneumophila) in human monocytes is reversibly inhibited by erythromycin and rifampin","volume":"71","author":"Horwitz","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(78)90611-6","article-title":"Antibiotic treatment of guinea pigs infected with agent of Legionnaire's disease","volume":"i","author":"Fraser","year":"1978","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib10","first-page":"152","volume":"26","author":"Nash","year":"1977","journal-title":"Morbid Mortal Wkly Rep"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/313959","article-title":"Canadian guidelines for the initial management of community\u2010acquired pneumonia: evidence\u2010based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society","volume":"31","author":"Mandell","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/313954","article-title":"Practice guidelines for the management of community\u2010acquired pneumonia in adults","volume":"31","author":"Bartlett","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib13","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1164\/ajrccm.163.7.at1010","article-title":"Guidelines for the management of adults with community\u2010acquired pneumonia. Diagnosis assessment of severity, antimicrobial therapy, and prevention","volume":"163","author":"Niederman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1086\/377534","article-title":"An international prospective study of pneumococcal bacteremia: Correlation with in vitro resistance, antibiotics administered and clinical outcome","volume":"37","author":"Yu","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib15","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1086\/428049","article-title":"Antimicrobial chemotherapy for Legionnaire's disease: levofloxacin versus macrolides","volume":"40","author":"Blazquez\u2010Garrido","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib16","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1086\/428059","article-title":"Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy","volume":"40","author":"Mykietiuk","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib17","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1378\/chest.128.3.1401","article-title":"For the Legionniares' disease therapy group. Fluoroquinolones versus macrolides in the treatment of Legionnaire's disease","volume":"128","author":"Sabri\u00e0","year":"2005","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib18","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1378\/chest.125.6.2135","article-title":"Levofloxacin efficacy in the treatment of community\u2010acquired legionellosis","volume":"125","author":"Yu","year":"2004","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib19","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1086\/431768","article-title":"Levofloxacin and macrolides for treatment of Legionnaire's disease: multiple comparisons give few answers","volume":"41","author":"Kraus","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib20","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/clinids\/17.3.518","article-title":"Unsuccessful treatment of Legionella pneumophila infection with a fluoroquinolone","volume":"17","author":"Salord","year":"1993","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 5A","key":"10.1111\/j.1469-0691.2006.01394.x_bib21","doi-asserted-by":"crossref","first-page":"128S","DOI":"10.1016\/0002-9343(89)90041-7","article-title":"Ciprofloxacin in the treatment of legionellosis in critically ill patients including those cases unresponsive to erythromycin","volume":"87","author":"Unertl","year":"1989","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/jac\/22.3.389","article-title":"Failure of treatment of Legionella pneumophila with ciprofloxacin","volume":"22","author":"Kurz","year":"1988","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1086\/516258","article-title":"Role of immunosuppression in the evolution of Legionnaire's disease","volume":"26","author":"Pedro\u2010Botet","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib24","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1378\/chest.124.2.543","article-title":"Legionnaire's disease and HIV infection","volume":"124","author":"Pedro\u2010Botet","year":"2003","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib25","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/archinte.1994.00420210049006","article-title":"Surveillance for Legionnaire's disease: risk factors for morbidity and mortality","volume":"154","author":"Marston","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib26","first-page":"132","article-title":"Legionella: a major opportunistic pathogen in transplant recipients","volume":"13","author":"Chow","year":"1998","journal-title":"Seminars Respiratory Infections"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0163-4453(85)92413-2","article-title":"The effect of antibiotics on the growth of Legionella pneumophila in guinea\u2010pig alveolar phagocytes infected in vivo by an aerosol","volume":"10","author":"Fitzgeorge","year":"1985","journal-title":"J Infect"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib28","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1128\/AAC.31.10.1529","article-title":"Effect of quinolones and other antimicrobial agents on cell\u2010associated Legionella pneumophila","volume":"31","author":"Havlichek","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. C","key":"10.1111\/j.1469-0691.2006.01394.x_bib29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/jac\/22.Supplement_C.53","article-title":"The effect of ofloxacin on the intracellular growth of Legionella pneumophila in guinea pig alveolar phagocytes","volume":"22","author":"Fitzgeorge","year":"1988","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib30","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1128\/AAC.33.12.2132","article-title":"WIN 57273 is bactericidal for Legionella pneumophila grown in alveolar macrophages","volume":"33","author":"Edelstein","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib31","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1128\/AAC.35.1.180","article-title":"In vitro activity of azithromycin against clinical isolates of Legionella species","volume":"35","author":"Edelstein","year":"1991","journal-title":"Antimicro Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib32","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/jac\/27.3.343","article-title":"Inhibition of Legionella pneumophila in guinea pig peritoneal macrophages by new quinolone, macrolide and other antimicrobial agents","volume":"27","author":"Kitsukawa","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jac\/37.1.117","article-title":"In\u2010vitro activity of levofloxacin against clinical isolates of Legionella spp. Its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia","volume":"37","author":"Edelstein","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0934-8840(97)80009-6","article-title":"Excellent activity of newer quinolones on Legionella pneumophila in J774 macrophages","volume":"285","author":"Walz","year":"1997","journal-title":"Zentralbl Bakteriol"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib35","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/jac\/40.5.673","article-title":"Effect of levofloxacin, erythromycin or rifampicin pretreatment on growth Legionella pneumophila in human monocytes","volume":"40","author":"Smith","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib36","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1128\/AAC.42.12.3153","article-title":"Antibacterial effects of levofloxacin, erythromycin and rifampinin human monocyte system against Legionella pneumophila","volume":"42","author":"Baltch","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0732-8893(97)00174-0","article-title":"Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL\u201060 cells","volume":"30","author":"Stout","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/jac\/41.2.289","article-title":"Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin\/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL\u201060 cells","volume":"41","author":"Stout","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib39","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1128\/AAC.43.1.90","article-title":"In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia","volume":"43","author":"Edelstein","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib40","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1128\/AAC.45.8.2204-2209.2001","article-title":"In vitro activity of gemifloxacin (SB\u2010265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia","volume":"45","author":"Edelstein","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib41","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/jac\/dki186","article-title":"Antibacterial activities of gemifloxacin, levofloxacin, gatifloxacin, moxifloxacin and erythromycin against intracellular Legionella pneumophila and Legionella micdadei in human monocytes","volume":"56","author":"Baltch","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib42","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ijantimicag.2004.08.019","article-title":"Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing","volume":"25","author":"Stout","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib43","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/jac\/dki159","article-title":"Pharmacodynamic studies of moxifloxacin and erythromycin against intracellular Legionella pneumophila in an in vitro kinetic model","volume":"56","author":"Tano","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib44","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/jac\/18.2.251","article-title":"The antimicrobial activity of ciprofloxacin against Legionella species and the treatment of experimental Legionella pneumonia in guinea pigs","volume":"18","author":"Saito","year":"1986","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib45","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/AAC.28.1.15","article-title":"Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs","volume":"28","author":"Saito","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib46","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1128\/AAC.45.8.2204-2209.2001","article-title":"In vitro activity of gemifloxacin (SB\u2010265805,LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with Legionella pneumonia","volume":"45","author":"Edelstein","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib47","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/BF01691575","article-title":"A comparative study on the efficacy of the new quinolone alatrofloxacin in the treatment of experimental legionellosis in guinea pigs","volume":"17","author":"Garc\u00eda de Lomas","year":"1998","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl. B","key":"10.1111\/j.1469-0691.2006.01394.x_bib48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/jac\/17.suppl_B.41","article-title":"Efficacy of pefloxacin in comparison with erythromycin in the treatment of experimental guinea pig legionellosis","volume":"17","author":"Dourmon","year":"1986","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib49","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1128\/AAC.34.11.2122","article-title":"In vitro activity of sparfloxacin (CI978; AT\u20104140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia","volume":"34","author":"Edelstein","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01394.x_bib50","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0934-8840(89)80027-1","article-title":"Pathogenesis and chemotherapy of experimental Legionella pneumophila infection in the chick embryo","volume":"271","author":"Tzianabos","year":"1989","journal-title":"Zentralbl Bakteriol"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14613197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14613197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T01:48:33Z","timestamp":1555552113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14613197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":50,"alternative-id":["S1198743X14613197"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2006.01394.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2006]]}}}